Michel Laverdière, Université de Montréal

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
Journal of Antimicrobial Chemotherapy · 2016
Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
Antimicrobial Agents and Chemotherapy · 2014
Why Candida Sepsis Should Matter to ICU Physicians
Critical Care Clinics · 2013 · senior author

All 6 publications

6 publications.

01

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Cornely OA, Duarte RF, Haider S, Chandrasekar P, Helfgott D, Jiménez JL, Candoni A, Raad I, Laverdiere M, Langston A

Journal of Antimicrobial Chemotherapy2016150 citationsOpen Access

DOI: 10.1093/jac/dkv380

02

Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia

Duarte RF, López-Jiménez J, Cornely OA, Laverdiere M, Helfgott D, Haider S, Chandrasekar P, Langston A, Perfect J, Ma L

Antimicrobial Agents and Chemotherapy2014110 citationsOpen Access

DOI: 10.1128/aac.03050-14

03

Why Candida Sepsis Should Matter to ICU Physicians

Yoanna Skrobik, Michél Laverdière

Critical Care Clinics201316 citationsSenior author

DOI: 10.1016/j.ccc.2013.06.007 PMID: 24094381

04

Serum β-d-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations.

Heyland D, Jiang X, Day AG, Laverdiere M

Journal of critical care201122 citationsSenior author

DOI: 10.1016/j.jcrc.2011.01.002 PMID: 21376516

05

Utility of the Germ Tube Test for Direct Identification of Candida albicans from Positive Blood Culture Bottles

Donald C. Sheppard, Marie‐Claude Locas, Christiane Restieri, Michél Laverdière

Journal of Clinical Microbiology200854 citationsSenior authorOpen Access

DOI: 10.1128/jcm.01113-08 PMID: 18685004

06

Susceptibility patterns of Candida species recovered from Canadian intensive care units

Laverdiere M, Labbé A-C, Restieri C, Rotstein C, Heyland D, Madger S, Stewart T

Journal of Critical Care200739 citationsFirst author

DOI: 10.1016/j.jcrc.2006.10.038

Frequent collaborators

Department of Medicine
Département de microbiologie et d’infectiologie
Department of Critical Care
Department of Microbiology and Immunology
Département de médecine

Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Shariq Haider

Department of Medicine

2 shared papers, latest 2016

Daren Heyland

Department of Critical Care

2 shared papers, latest 2011

Yoanna Skrobik

Département de médecine

1 shared papers, latest 2013

Thomas Stewart

Department of Medicine

1 shared papers, latest 2007

Donald Sheppard

Department of Microbiology and Immunology

1 shared papers, latest 2008

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Laverdière, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease" (2016), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Michel Laverdière